A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

about

SIRT1 promotes formation of breast cancer through modulating Akt activity.

P2860

Q55110307-B92DB6D8-B9F8-49D3-BD93-CCDB16F92B22

P2860

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

Item

http://www.wikidata.org/entity/Q36181844

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A network meta-analysis for to ...... astatic/advanced breast cancer

@ast

A network meta-analysis for to ...... astatic/advanced breast cancer

@en

type

Item

label

A network meta-analysis for to ...... astatic/advanced breast cancer

@ast

A network meta-analysis for to ...... astatic/advanced breast cancer

@en

prefLabel

A network meta-analysis for to ...... astatic/advanced breast cancer

@ast

A network meta-analysis for to ...... astatic/advanced breast cancer

@en

P1476

A network meta-analysis for to ...... astatic/advanced breast cancer

@en

P2093

Bo Gao

http://www.w3.org/2001/XMLSchema#string

Dong-Lin Luo

http://www.w3.org/2001/XMLSchema#string

Ling-Ji Guo

http://www.w3.org/2001/XMLSchema#string

Shu Zhang

http://www.w3.org/2001/XMLSchema#string

Shuai Hao

http://www.w3.org/2001/XMLSchema#string

Wu-Guo Tian

http://www.w3.org/2001/XMLSchema#string

Xiao-Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of ovarian cancer in elderly patients

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Topical henna ameliorated capecitabine-induced hand-foot syndrome

Combination of direct and indirect evidence in mixed treatment comparisons

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.

Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.

siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.

P304

84533-84543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.18632/ONCOTARGET.13023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27811367

http://www.w3.org/2001/XMLSchema#string

P932

5356679

http://www.w3.org/2001/XMLSchema#string

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

about

P2860

P2860

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932